EYE 0.00% 18.0¢ nova eye medical limited

POTENTIAL RE-RATE CATALYST EVENT: RESULTS, page-7

  1. 315 Posts.
    lightbulb Created with Sketch. 591
    Nice post (again) and good reading on a very wet Sunday morning here.

    The pie chart you posted from the most recent presentation really highlights our potential to grow. Over the past year we have mainly been focussed on the first two pieces of the pie A+B which is 500 accounts out of a market of 10,700 accounts. Hopefully management provide some more commentary around the timing and strategy to sell into the bigger piece - D.
    I've lost track of how many new sales reps we now have. Does anybody know?
    The presentation indicates we will go to 11 sales reps in time.

    As for expenses, we will see this in the August FY accounts. Im not too worried about EBITA as its about revenue for a business at this stage. The costs of recruiting, onboarding, training and attending these large conferences are very expensive especially when we raise in AUD and spend in USD. This is what some large potential investors may be wanting to understand further.

    As for our revenue multiple or P/S ratio, i'm just looking as a first step towards 5x to 8 x. And then as we boost sales to targeted accounts, roll out more products, 2rt updates, target the cataract market, etc, then the market should spike our multiple to high levels, possibly like PNV's P/S ratio.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
18.0¢
Change
0.000(0.00%)
Mkt cap ! $41.23M
Open High Low Value Volume
19.0¢ 19.0¢ 18.0¢ $24.11K 132.1K

Buyers (Bids)

No. Vol. Price($)
4 137086 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 30000 1
View Market Depth
Last trade - 14.41pm 04/10/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.